Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Abrams

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activitiesS I Abrams, Z Brahmi
Current Opinion in Immunology|February 19, 2000
Rational antigen modification as a strategy to upregulate or downregulate antigen recognitionS I Abrams, J Schlom
Annales De L'Institut Pasteur. Immunology|July 1, 1988
Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assayS I Abrams, Z Brahmi
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytesS I Abrams, Z Brahmi
Cellular Immunology|September 1, 1986
The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanismS I Abrams, Z Brahmi
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
CD4+ T lymphocyte-induced target cell detachment. A model for T cell-mediated lytic and nonlytic inflammatory processesS I Abrams, J H Russell
Cancer Immunology, Immunotherapy : CII|February 28, 2001
Characterization of CD8+ cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinantM Hilburger Ryan, S I Abrams
Oncogene|October 7, 2008
How tumours escape mass destructionT J Stewart, S I Abrams
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTLE S Bergmann-Leitner, S I Abrams
Cancer Immunology, Immunotherapy : CII|August 15, 2000
Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attackE S Bergmann-Leitner, S I Abrams
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activitiesS I Abrams, Z Brahmi
Current Opinion in Immunology|February 19, 2000
Rational antigen modification as a strategy to upregulate or downregulate antigen recognitionS I Abrams, J Schlom
Annales De L'Institut Pasteur. Immunology|July 1, 1988
Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assayS I Abrams, Z Brahmi
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytesS I Abrams, Z Brahmi
Cellular Immunology|September 1, 1986
The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanismS I Abrams, Z Brahmi
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
CD4+ T lymphocyte-induced target cell detachment. A model for T cell-mediated lytic and nonlytic inflammatory processesS I Abrams, J H Russell
Cancer Immunology, Immunotherapy : CII|February 28, 2001
Characterization of CD8+ cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinantM Hilburger Ryan, S I Abrams
Oncogene|October 7, 2008
How tumours escape mass destructionT J Stewart, S I Abrams
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTLE S Bergmann-Leitner, S I Abrams
Cancer Immunology, Immunotherapy : CII|August 15, 2000
Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attackE S Bergmann-Leitner, S I Abrams
Pageof 4